Skip to main navigation Skip to search Skip to main content

A Mutlicenter, Randomized, Double-Blind, Placebo-Controlled Trial os Emricasan (IDN-6556), an Oral Caspase Inhibitor, in Subjects with Non-alcoholic Steatohepatitis (NASH) Fibrosis

    Project: Research

    Project Details

    StatusActive
    Effective start/end date12/7/16 → …